Latest Retail News

Page 42 of 157
Jumbo Interactive’s preliminary 1H26 results reveal robust double-digit growth driven by SaaS and Managed Services, despite a quieter jackpot landscape. The recent acquisitions in the UK and US add momentum but introduce new accounting complexities.
Sophie Babbage
Sophie Babbage
4 Feb 2026
Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.
Claire Turing
Claire Turing
3 Feb 2026
Pinnacle Investment Management reported a solid 13% increase in funds under management to $202.5 billion despite an 11% drop in half-year profit. The company declared a 29 cent interim dividend and advanced its international expansion with key acquisitions.
Claire Turing
Claire Turing
3 Feb 2026
Retail Food Group has refinanced its senior debt with a new $41.2 million facility to back its Enhance & Grow strategy, while updating earnings guidance amid challenging trading conditions.
Victor Sage
Victor Sage
3 Feb 2026
Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.
Maxwell Dee
Maxwell Dee
3 Feb 2026
Briscoe Group Limited has reported record sales for both the fourth quarter and full-year 2026, alongside improved gross margins and a growing online presence.
Logan Eniac
Logan Eniac
3 Feb 2026
Yowie Group has landed a three-year seasonal licence to produce and distribute beloved Australian confectionery brands Violet Crumble, Polly Waffle, and FruChocs across Australia and New Zealand, targeting $6.5 million in net sales.
Victor Sage
Victor Sage
2 Feb 2026
PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.
Ada Torres
Ada Torres
2 Feb 2026
PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.
Ada Torres
Ada Torres
2 Feb 2026
Genetic Signatures has appointed Maria Halasz as its new CEO, bringing over two decades of leadership in life sciences and capital markets to steer the company’s global expansion.
Ada Torres
Ada Torres
2 Feb 2026
KMD Brands reports strong sales momentum in the first five months of FY26, led by Kathmandu’s impressive growth in Australia and New Zealand, while EBITDA guidance signals a significant profit uplift.
Logan Eniac
Logan Eniac
2 Feb 2026
Axtec Limited maintains a steady cash position through strategic equity placements and cost reductions while advancing its PropTech platform and partnerships.
Sophie Babbage
Sophie Babbage
30 Jan 2026